Indian Journal of Surgical Oncology

, Volume 4, Issue 1, pp 59–66

Human Papilloma Virus in Head and Neck Cancers—Role and Relevance in Clinical Management

Review Article


The biology and clinical behavior of Head and Neck Squamous Cell Carcinomas (HNSCCs) is very distinct within different subgroups due to the distinct molecular profiles for the HPV positive versus HPV negative tumors. HPV status is the most important independent prognostic variable in multivariate analysis taking into account all other prognostic factors like tumour stage, smoking status, age and performance status. The debate today is whether the intense therapy is too aggressive in this group of patients since they show a superior survival regardless of treatment strategies. A highly divergent prognosis and distinct biology of HPV positive and HPV negative HNSCCs underlines the fact that treating them as distinct diseases is the need of the hour. Infection with HPV is associated with less aggressive disease, better loco regional control and lower rates of second primary cancers. An important caveat that remains is the emergence of intermediate prognosis of HPV positive smokers and HPV negative non smokers. Though molecular biology has provided important data on the interaction of the HPV onco proteins with genes important in cell cycle control, also speculated to be involved in pathogenesis of HNSCC, more basic research is needed to describe the differential mechanisms of tumorigenesis among the HNSCCs that show presence and absence of HPV. This is clinically relevant to reduce morbidity without compromising tumour control in HPV positive patients and improving tumour control and co-morbid illness that could be pre-existing or treatment related in HPV negative patients. There may be a need for treatment intensification and incorporation of newer agents into induction chemotherapy protocols for the HPV negative patients and so HPV detection is important to aid in this selection. HPV tumour status is therefore more important than just providing the prognostic information in these classes of tumours. This article discusses the role and clinical relevance of HPV in HNSCCs.


HPV status Head and neck squamous cell carcinoma Prognostic indicators Tumorigenesis mechanism in HPV positive head and neck cancers 


  1. 1.
    Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB (2006) Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 6:1111–1118PubMedCrossRefGoogle Scholar
  2. 2.
    Syrjanen K, Syrjanen S, Lamberg M, Pyrhonen S, Nuutinen J (1983) Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 12:418–424PubMedCrossRefGoogle Scholar
  3. 3.
    Shin KH, Min BM, Cherrick HM, Park NH (1994) Combined effects of human papillomavirus-18 and N-methyl-N’-nitro-N-nitrosoguanidine on the transformation of normal human oral keratinocytes. Mol Carcinog 9:76–86PubMedCrossRefGoogle Scholar
  4. 4.
    zur Hausen H, de Villiers EM, Gissmann L (1981) Papillomavirus infections and human genital cancer. Gynecol Oncol 12:124–128CrossRefGoogle Scholar
  5. 5.
    Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J ClinPathol 55:244–265Google Scholar
  6. 6.
    Miller CS, Johnstone BM (2001) Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 91(6):622–635CrossRefGoogle Scholar
  7. 7.
    Ha PK, Califano JA (2004) The role of human papillomavirus in oral carcinogenesis. Crit Rev Oral Biol Med 15:188–196PubMedCrossRefGoogle Scholar
  8. 8.
    Human papilloma viruses (2007) IARC Monogr Eval Carcinog Risks Hum 90:1–636Google Scholar
  9. 9.
    Hansson BG, Rosenquist K, Antonsson A, Wennerberg J, Schildt EB, Bladström A, Andersson G (2005) Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case–control study in southern Sweden. Acta Otolaryngol 125:1337–1344PubMedCrossRefGoogle Scholar
  10. 10.
    Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomark Prev 14:467–475CrossRefGoogle Scholar
  11. 11.
    Thavaraj S, Stokes A, Guerra E, Bible J, Halligan E, Long A, Okpokam A, Sloan P, Odell E, Robinson M (2011) Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. J Clin Pathol 64:308–312PubMedCrossRefGoogle Scholar
  12. 12.
    Näsman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, Ramqvist T, Lindholm J, Sparén P, Ye W, Dahlstrand H, Munck-Wikland E, Dalianis T (2006) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125:362–366CrossRefGoogle Scholar
  13. 13.
    Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML (2011) Human papillomavirus (HPV) and rising oropharyngeal cancer incidence and survival in the United States. J Clin Oncol 29:4294–4301PubMedCrossRefGoogle Scholar
  14. 14.
    Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008) Incidence trends for human papilloma virus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26:612–619PubMedCrossRefGoogle Scholar
  15. 15.
    Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, Wu X, Chaturvedi AK, Kawaoka K (2008) Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998–2003. Cancer 113:2901–2909PubMedCrossRefGoogle Scholar
  16. 16.
    Auluck A, Hislop G, Bajdik C, Poh C, Zhang L, Rosin M (2010) Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer 116:2635–2644PubMedGoogle Scholar
  17. 17.
    Hocking JS, Stein A, Conway EL, Regan D, Grulich A, Law M, Brotherton JM (2011) Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 104:886–891PubMedCrossRefGoogle Scholar
  18. 18.
    Pierce JP, Messer K, White MM, Cowling DW, Thomas DP (2011) Prevalence of heavy smoking in California and the United States, 1965–2007. JAMA 305:1106–1112PubMedCrossRefGoogle Scholar
  19. 19.
    Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU et al (1995) Human papilloma virus in 91 oral Indian betel quid chewers: High prevelance and multiplicity of infections. Int J Cancer 61:450–454PubMedCrossRefGoogle Scholar
  20. 20.
    D’Costa J, Saranath D, Dedhia P, Sanghvi V, Mehta AR (1998) Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 34:413–420PubMedCrossRefGoogle Scholar
  21. 21.
    Nagpal JK, Patnaik S, Das BR (2002) Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 10(97):649–653CrossRefGoogle Scholar
  22. 22.
    Pillai MR, Nair MK (2000) Development of a condemned mucosa syndrome and pathogenesis of human papilloma virus-associated upper aerodigestive tract and uterine cervical tumors. Exp Mol Pathol 69:233–241PubMedCrossRefGoogle Scholar
  23. 23.
    Agius PA, Pitts MK, Smith AM, Mitchell A (2010) Sexual behaviour and related knowledge among a representative sample of secondary school students between 1997 and 2008. Aust N Z J Public Health 34:476–481PubMedCrossRefGoogle Scholar
  24. 24.
    Aral SO, Patel DA, Holmes KK, Foxman B (2005) Temporal trends in sexual behaviors and sexually transmitted disease history among 18- to 39-year-old Seattle, Washington, residents: results of random digit-dial surveys. Sex Transm Dis 32:710–717PubMedCrossRefGoogle Scholar
  25. 25.
    Bajos N, Bozon M, Beltzer N, Laborde C, Andro A, Ferrand M, Goulet V, Laporte A, Le Van C, Leridon H, Levinson S, Razafindratsima N, Toulemon L, Warszawski J, Wellings K (2010) Changes in sexual behaviours: from secular trends to public health policies. AIDS 24:1185–1191PubMedCrossRefGoogle Scholar
  26. 26.
    Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ (2008) Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123:187–194PubMedCrossRefGoogle Scholar
  27. 27.
    Gillison ML (2009) Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection. Curr Opin Oncol 21:439–444PubMedCrossRefGoogle Scholar
  28. 28.
    D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML (2007) Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944–1956PubMedCrossRefGoogle Scholar
  29. 29.
    Koskinen WJ, Chen RW, Leivo I, Mäkitie A, Bäck L, Kontio R, Suuronen R, Lindqvist C, Auvinen E, Molijn A, Quint WG, Vaheri A, Aaltonen LM (2003) Prevalence and physical status of humanpapillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 107(3):401–406PubMedCrossRefGoogle Scholar
  30. 30.
    Syrjanen S (2004) HPV infections and tonsillar carcinoma. J Clin Pathol 57:449–455PubMedCrossRefGoogle Scholar
  31. 31.
    Braakhuis BJM, Snijders PJF, Keune W-JH, Meijer CJLM, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH (2004) Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 96(13):998–1006PubMedCrossRefGoogle Scholar
  32. 32.
    Zheng ZM, Baker C (2006) Papillomavirus genome structure, expression and post translational regulation. Front Biosci 11:2286–2302PubMedCrossRefGoogle Scholar
  33. 33.
    Ragin CC, Taioli E (2007) Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta analysis. Int J Cancer 121:1813–1820PubMedCrossRefGoogle Scholar
  34. 34.
    Smith EM, Rubenstein LM, Haugen TH, Pawlita M, Turek LP (2012) Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol 2012:571862PubMedCrossRefGoogle Scholar
  35. 35.
    Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24–35PubMedCrossRefGoogle Scholar
  36. 36.
    Attner P, Du J, Näsman A, Hammarstedt L, Ramqvist T, Lindholm J, Marklund L, Dalianis T, Munck-Wikland E (2010) The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer 126:2879–2884PubMedGoogle Scholar
  37. 37.
    Sedaghat AR, Zhang Z, Begum S, Palermo R, Best S, Ulmer KM, Levine M, Zinreich E, Messing BP, Gold D, Wu AA, Niparko KJ, Kowalski J, Hirata RM, Saunders JR, Westra WH, Pai SI (2008) Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope 119:1542–1549CrossRefGoogle Scholar
  38. 38.
    Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269PubMedCrossRefGoogle Scholar
  39. 39.
    Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ (2009) Winquist EW Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 20:921–927PubMedCrossRefGoogle Scholar
  40. 40.
    Pang E, Delic NC, Hong A, Zhang M, Rose BR, Lyons JG (2011) Radiosensitization of oropharyngeal squamous cell carcinoma cells by human papillomavirus 16 oncoprotein E6∗I. Int J Radiat Oncol Biol Phys 79:860–865PubMedCrossRefGoogle Scholar
  41. 41.
    Young RJ, Rischin D, Fisher R, McArthur GA, Fox SB, Peters LJ, Corry J, Lim A, Waldeck K, Solomon B (2011) Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 20:1230–1237PubMedCrossRefGoogle Scholar
  42. 42.
    Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M, Dalianis T (2002) Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102:152–158PubMedCrossRefGoogle Scholar
  43. 43.
    Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A (2006) Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 24:736–747PubMedCrossRefGoogle Scholar
  44. 44.
    Mehanna H, Olaleye O, Licitra L (2012) Oropharyngeal cancer - is it time to change management according to human papilloma virus status? Curr Opin Otolaryngol Head Neck Surg 20:120–124PubMedCrossRefGoogle Scholar
  45. 45.
    Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JM, D’Silva NJ, Yang K, Kurnit DM, Bauer JA, Bradford CR, Carey TE (2008) EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 26:3128–3137PubMedCrossRefGoogle Scholar
  46. 46.
    Hong A, Dobbins T, Lee CS, Jones D, Jackson E, Clark J, Armstrong B, Harnett G, Milross C, O’Brien C, Rose B (2010) Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer. Eur J Cancer 46:2088–2096PubMedCrossRefGoogle Scholar
  47. 47.
    Gillison ML, Chaturvedi AK, Lowy DR (2008) HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 113:3036–3046PubMedCrossRefGoogle Scholar
  48. 48.
    Wu AA, Niparko KJ, Pai SI (2008) Immunotherapy for head and neck cancer. J Biomed Sci 15:275–289PubMedCrossRefGoogle Scholar

Copyright information

© Indian Association of Surgical Oncology 2012

Authors and Affiliations

  • Vijayalakshmi Ramshankar
    • 1
  • Arvind Krishnamurthy
    • 2
  1. 1.Department of Preventive OncologyCancer Institute (WIA)ChennaiIndia
  2. 2.Departments of Surgical OncologyCancer Institute (WIA)ChennaiIndia

Personalised recommendations